SC 13G | 2018-11-26 | SABBY MANAGEMENT, LLC | DelMar Pharmaceuticals, Inc. | 800,000 | 3.3% | EDGAR |
SC 13G/A | 2018-02-13 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 1,800,000 | 7.7% | EDGAR |
SC 13G/A | 2018-02-06 | FRANKLIN RESOURCES INC | DelMar Pharmaceuticals, Inc. | 1,884,616 | 8.4% | EDGAR |
SC 13G/A | 2018-01-08 | SABBY MANAGEMENT, LLC | DelMar Pharmaceuticals, Inc. | 1,077,914 | 5.0% | EDGAR |
SC 13G/A | 2017-10-10 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 2,000,000 | 8.6% | EDGAR |
SC 13G | 2017-09-28 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 1,121,417 | 5.0% | EDGAR |
SC 13D | 2017-06-12 | Garner William J | DelMar Pharmaceuticals, Inc. | 612,393 | - | EDGAR |
SC 13G | 2017-05-10 | FRANKLIN RESOURCES INC | DelMar Pharmaceuticals, Inc. | 1,884,615 | 13.2% | EDGAR |
SC 13G | 2017-04-13 | SABBY MANAGEMENT, LLC | DelMar Pharmaceuticals, Inc. | 461,536 | 3.4% | EDGAR |
SC 13D | 2016-05-10 | Garner William J | DelMar Pharmaceuticals, Inc. | 2,465,207 | - | EDGAR |
SC 13D/A | 2014-10-31 | BACHA JEFFREY | DelMar Pharmaceuticals, Inc. | 4,049,527 | 11.1% | EDGAR |
SC 13G | 2014-10-31 | Garner William J | DelMar Pharmaceuticals, Inc. | 2,668,541 | 8.1% | EDGAR |
SC 13D/A | 2014-09-17 | BACHA JEFFREY | DelMar Pharmaceuticals, Inc. | 6,434,068 | 17.6% | EDGAR |
SC 13D/A | 2013-09-19 | Brown Dennis M | DelMar Pharmaceuticals, Inc. | 3,981,042 | 16.0% | EDGAR |
SC 13D/A | 2013-09-19 | BACHA JEFFREY | DelMar Pharmaceuticals, Inc. | 6,924,583 | 22.5% | EDGAR |
SC 13D | 2013-02-13 | BACHA JEFFREY | DelMar Pharmaceuticals, Inc. | 6,837,083 | 27.9% | EDGAR |
SC 13D | 2013-02-13 | Brown Dennis M | DelMar Pharmaceuticals, Inc. | 3,893,542 | 20.9% | EDGAR |
SC 13G | 2013-02-04 | Vollintine Raymond L. | DelMar Pharmaceuticals, Inc. | 2,031,000 | 10.9% | EDGAR |
SC 13G | 2013-02-04 | FUGUET HOWARD K | DelMar Pharmaceuticals, Inc. | 2,500,000 | 13.2% | EDGAR |
SC 13G | 2013-02-01 | Newsome Robert Michael | DelMar Pharmaceuticals, Inc. | 1,152,500 | 6.8% | EDGAR |